Joshua Zeidner Archives - UNC Lineberger

June 16, 2025

ASCO Post: Revumenib in Triplet Regimen Under Study in Newly Diagnosed AML With NPM1/KMT2A Alterations

Human cells with acute myelocytic leukemia (AML) in the pericardial fluid, shown with an esterase stain at 400x magnification.

Joshua Zeidner, MD, and colleagues report that a combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia showed high rates of complete remission in an early-phase clinical trial.

66th ASH Annual Meeting and Exposition. December 7-10, 2024 in San Diego, California.

Nearly two dozen UNC faculty members and trainees will present research and participate in scientific symposia and educational sessions at the ASH Annual Meeting.

A smiling physician rests his hand on a patient's shoulder in a reassuring gesture.

Joshua Zeidner, MD, a hematologist/oncologist specializing in the management of acute leukemia, explains some of the advances in the treatment of acute myeloid leukemia (AML).

American Society of Hematology Annual Meeting

UNC Lineberger researchers will present the latest findings from studies and lead educational sessions at the 64th American Society of Hematology Annual Meeting in New Orleans, Dec. 10-13.

Using the wrong mathematical formula to assess heartbeat rhythms may lead oncologists to inappropriately stop life-saving chemotherapy, according to research findings from UNC Lineberger scientists.

The Alstons at the sweetheart table at their wedding

When a significant other is diagnosed with cancer, it can be just as hard on the loved one as it is on the patient. However, Stephen and Jackie Alston found themselves experiencing both roles when they were each diagnosed with cancer years apart.

Tag: Joshua Zeidner

ASCO Post: Revumenib in Triplet Regimen Under Study in Newly Diagnosed AML With NPM1/KMT2A Alterations

Novel drug combination is safe and benefits people with acute myeloid leukemia who have a specific genetic profile

ASCO Post: Novel Menin Inhibitors Show Safety and Activity in Several Clinical Trials

UNC researchers presenting research advances at American Society of Hematology annual meeting

EMJ Podcast: Insights For Healthcare Professionals: Hema Now: Episode 4: Navigating Acute Myeloid Leukaemia

New treatments offer promise to people with acute myeloid leukemia

UNC Lineberger and UNC researchers discuss latest research at American Society of Hematology Annual Meeting

Accurate assessment of heart rhythm can optimize chemotherapy use

Couple unified through cancer, caregiver struggles

GEN: Immunotherapy Post Chemotherapy Shows Positive Results in Acute Myeloid Leukemia